Back to all journals
journal articles
CONSEQUENCES OF THE FDA DECISION ON ADUCANUMAB FOR PATIENT CARE AND RESEARCH
R. Doody
J Prev Alz Dis 2021;4(8):393-395
CITATION:
R. Doody (2021): Consequences of the FDA Decision on Aducanumab for Patient Care and Research. The Journal of Prevention of Alzheimer’s Disease (JPAD). http://dx.doi.org/10.14283/jpad.2021.43